In particular, the mutation frequency for ATM is 0.78% and for CHEK2 1.08% in unselected breast cancer patients, whereas the prevalence in unaffected women is 0.41% for ATM and 0.42% for CHEK2 [3]. This evidence concerns the gene CHEK2 and breast cancer.